Mortality patterns over a 10-year period in Kibera, an urban informal settlement in Nairobi, Kenya, 2009-2018.


Journal

Global health action
ISSN: 1654-9880
Titre abrégé: Glob Health Action
Pays: United States
ID NLM: 101496665

Informations de publication

Date de publication:
31 12 2023
Historique:
medline: 26 7 2023
pubmed: 25 7 2023
entrez: 25 7 2023
Statut: ppublish

Résumé

Reliable mortality data are important for evaluating the impact of health interventions. However, data on mortality patterns among populations living in urban informal settlements are limited. To examine the mortality patterns and trends in an urban informal settlement in Kibera, Nairobi, Kenya. Using data from a population-based surveillance platform we estimated overall and cause-specific mortality rates for all age groups using person-year-observation (pyo) denominators and using Poisson regression tested for trends in mortality rates over time. We compared associated mortality rates across groups using incidence rate ratios (IRR). Assignment of probable cause(s) of death was done using the InterVA-4 model. We registered 1134 deaths from 2009 to 2018, yielding a crude mortality rate of 4.4 (95% Confidence Interval [CI]4.2-4.7) per 1,000 pyo. Males had higher overall mortality rates than females (incidence rate ratio [IRR], 1.44; 95% CI, 1.28-1.62). The highest mortality rate was observed among children aged < 12 months (41.5 per 1,000 pyo; 95% CI 36.6-46.9). All-cause mortality rates among children < 12 months were higher than that of children aged 1-4 years (IRR, 8.5; 95% CI, 6.95-10.35). The overall mortality rate significantly declined over the period, from 6.7 per 1,000 pyo (95% CI, 5.7-7.8) in 2009 to 2.7 (95% CI, 2.0-3.4) per 1,000 pyo in 2018. The most common cause of death was acute respiratory infections (ARI)/pneumonia (18.1%). Among children < 5 years, the ARI/pneumonia deaths rate declined significantly over the study period (5.06 per 1,000 pyo in 2009 to 0.61 per 1,000 pyo in 2018; Overall and some cause-specific mortality rates declined over time, representing important public health successes among this population.

Sections du résumé

BACKGROUND
Reliable mortality data are important for evaluating the impact of health interventions. However, data on mortality patterns among populations living in urban informal settlements are limited.
OBJECTIVES
To examine the mortality patterns and trends in an urban informal settlement in Kibera, Nairobi, Kenya.
METHODS
Using data from a population-based surveillance platform we estimated overall and cause-specific mortality rates for all age groups using person-year-observation (pyo) denominators and using Poisson regression tested for trends in mortality rates over time. We compared associated mortality rates across groups using incidence rate ratios (IRR). Assignment of probable cause(s) of death was done using the InterVA-4 model.
RESULTS
We registered 1134 deaths from 2009 to 2018, yielding a crude mortality rate of 4.4 (95% Confidence Interval [CI]4.2-4.7) per 1,000 pyo. Males had higher overall mortality rates than females (incidence rate ratio [IRR], 1.44; 95% CI, 1.28-1.62). The highest mortality rate was observed among children aged < 12 months (41.5 per 1,000 pyo; 95% CI 36.6-46.9). All-cause mortality rates among children < 12 months were higher than that of children aged 1-4 years (IRR, 8.5; 95% CI, 6.95-10.35). The overall mortality rate significantly declined over the period, from 6.7 per 1,000 pyo (95% CI, 5.7-7.8) in 2009 to 2.7 (95% CI, 2.0-3.4) per 1,000 pyo in 2018. The most common cause of death was acute respiratory infections (ARI)/pneumonia (18.1%). Among children < 5 years, the ARI/pneumonia deaths rate declined significantly over the study period (5.06 per 1,000 pyo in 2009 to 0.61 per 1,000 pyo in 2018;
CONCLUSIONS
Overall and some cause-specific mortality rates declined over time, representing important public health successes among this population.

Identifiants

pubmed: 37490025
doi: 10.1080/16549716.2023.2238428
pmc: PMC10392302
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2238428

Références

Am J Trop Med Hyg. 2016 Jan;94(1):122-127
pubmed: 26598567
Lancet Respir Med. 2016 Nov;4(11):852-854
pubmed: 27760724
Lancet Respir Med. 2014 Oct;2(10):823-60
pubmed: 25193349
J Urban Health. 2015 Jun;92(3):422-45
pubmed: 25758599
BMC Med. 2018 Mar 1;16(1):32
pubmed: 29495961
PLoS Med. 2007 Nov 20;4(11):e333
pubmed: 18031198
Toxics. 2016 Jul 13;4(3):
pubmed: 29051417
Urban Stud. 2011;48(5):947-57
pubmed: 21744541
Health Place. 2012 Sep;18(5):1144-52
pubmed: 22591621
Popul Health Metr. 2008 Mar 10;6:1
pubmed: 18331630
Lancet. 2007 Nov 3;370(9598):1569-77
pubmed: 17992727
Bull World Health Organ. 2005 Mar;83(3):171-7
pubmed: 15798840
Glob Health Action. 2014 Oct 29;7:25533
pubmed: 25377336
Popul Health Metr. 2014 May 14;12:14
pubmed: 24982595
Lancet. 2015 Oct 3;386(10001):1395-1406
pubmed: 25971218
J Urban Health. 2019 Dec;96(6):797-812
pubmed: 31218502
BMC Med. 2019 May 30;17(1):102
pubmed: 31146736
Popul Health Metr. 2011 Jul 27;9:20
pubmed: 21794100
Lancet Glob Health. 2019 Feb;7(2):e249-e256
pubmed: 30683242
Trop Med Infect Dis. 2017 Sep 16;2(3):
pubmed: 30270904
Lancet. 2018 Nov 10;392(10159):1684-1735
pubmed: 30496102
Popul Health Metr. 2017 Jul 17;15(1):27
pubmed: 28716042
Bull World Health Organ. 2014 Nov 1;92(11):807-16
pubmed: 25378742
BMC Infect Dis. 2012 Apr 20;12:95
pubmed: 22520624
PLoS Med. 2021 Feb 16;18(2):e1003537
pubmed: 33591995
PLoS One. 2014 Jan 28;9(1):e85913
pubmed: 24489678
PLoS One. 2011 Jan 18;6(1):e16085
pubmed: 21267459

Auteurs

Clifford Oduor (C)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Irene Omwenga (I)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Alice Ouma (A)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Robert Mutinda (R)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Samwel Kiplangat (S)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Ondari D Mogeni (OD)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Epidemiology, Public Health, Implementation & Clinical Development Unit, International Vaccine Institute (IVI), Seoul, South Korea.

Leonard Cosmas (L)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.

Allan Audi (A)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.

George S Odongo (GS)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

David Obor (D)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.

Robert Breiman (R)

The Emory Global Health Institute, Emory University, Atlanta, GA, USA.

Joel Montgomery (J)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

George Agogo (G)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya.

Patrick Munywoki (P)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya.

Godfrey Bigogo (G)

Centre for Global Health Research, Kenya Medical Research Institute (KEMRI), Kisumu, Kenya.

Jennifer R Verani (JR)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH